- Home
- LEGH vs CBLL Comparison
LEGH vs CBLL Comparison
Compare LEGH & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGH
- CBLL
- Stock Information
- Founded
- LEGH 2005
- CBLL 2014
- Country
- LEGH United States
- CBLL United States
- Employees
- LEGH N/A
- CBLL N/A
- Industry
- LEGH Homebuilding
- CBLL
- Sector
- LEGH Consumer Discretionary
- CBLL
- Exchange
- LEGH Nasdaq
- CBLL Nasdaq
- Market Cap
- LEGH 608.5M
- CBLL 698.0M
- IPO Year
- LEGH 2018
- CBLL 2024
- Fundamental
- Price
- LEGH $24.21
- CBLL $14.85
- Analyst Decision
- LEGH Buy
- CBLL Strong Buy
- Analyst Count
- LEGH 2
- CBLL 6
- Target Price
- LEGH $29.00
- CBLL $33.00
- AVG Volume (30 Days)
- LEGH 84.3K
- CBLL 372.9K
- Earning Date
- LEGH 05-08-2025
- CBLL 05-14-2025
- Dividend Yield
- LEGH N/A
- CBLL N/A
- EPS Growth
- LEGH 14.29
- CBLL N/A
- EPS
- LEGH 2.48
- CBLL N/A
- Revenue
- LEGH $184,191,000.00
- CBLL $65,444,000.00
- Revenue This Year
- LEGH $3.55
- CBLL $30.48
- Revenue Next Year
- LEGH $8.46
- CBLL $29.52
- P/E Ratio
- LEGH $9.76
- CBLL N/A
- Revenue Growth
- LEGH N/A
- CBLL 44.71
- 52 Week Low
- LEGH $19.42
- CBLL $10.01
- 52 Week High
- LEGH $29.31
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- LEGH 45.98
- CBLL N/A
- Support Level
- LEGH $23.37
- CBLL N/A
- Resistance Level
- LEGH $25.35
- CBLL N/A
- Average True Range (ATR)
- LEGH 1.26
- CBLL 0.00
- MACD
- LEGH 0.01
- CBLL 0.00
- Stochastic Oscillator
- LEGH 58.29
- CBLL 0.00
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.